New World Medical Achieves MDR Certification for Key Glaucoma Products

New World Medical Achieves Major Milestone with MDR Certification

New World Medical, a leader in innovative surgical devices designed to improve glaucoma treatment, has proudly announced that its flagship products—the Ahmed® Glaucoma Valve (AGV), Ahmed ClearPath® (ACP), and KDB GLIDE®—have officially received certification under the Medical Device Regulation (MDR) of the European Union. This significant milestone underscores the company's ongoing commitment to advancing glaucoma treatment and improving access to effective therapies for surgeons and patients around the world.

The journey towards MDR certification represents a successful transition from the previous Medical Device Directive (MDD) framework to the updated EU regulatory standards. Raymond Kong, Vice President of Sales at New World Medical, expressed pride in reaching this crucial achievement, stating, "The MDR certification reflects the immense effort and collaboration across our entire company, enabling us to continue supporting glaucoma surgeons in Europe with innovative solutions for their patients."

With this certification in place, New World Medical is not resting on its laurels; the company is already focused on obtaining MDR certification for more products within its portfolio. A key area of concentration is the Ahmed ClearPath® ST (ACP ST), which has already gained approval in over 20 countries and has proven to be a preferred option for surgeons treating refractory glaucoma.

Kong further noted, "European surgeons are showing increased interest in ACP ST, a next-generation glaucoma drainage system featuring a smaller drainage tube that allows for greater surgical flexibility. The MDR certification of ACP is a pivotal step in our European growth strategy, establishing a solid regulatory foundation for expanding the Ahmed ClearPath portfolio, including ACP ST. We are actively collaborating with our notified body to secure MDR certification for ACP ST and make this innovative technology accessible to surgeons across Europe."

The success of obtaining MDR certification strengthens New World Medical's global glaucoma portfolio, aligning with the company's mission to preserve and enhance vision through innovative solutions for patients worldwide. By focusing on the development and manufacturing of surgical devices aimed at maintaining the sight of glaucoma patients, New World Medical is dedicated to creating impactful treatment options that truly serve humanity.

The product lineup from New World Medical includes not only the leading glaucoma drainage system—the Ahmed® Glaucoma Valve—but also features such innovations as the Ahmed ClearPath®, KDB GLIDE®, the STREAMLINE® Surgical System, and the VIA360™ Surgical System.

For more information about New World Medical and its range of products, visit New World Medical.